Brief: Tianjin Development Says Lisheng Pharmaceutical To Subscribe For Wealth Management Products
06/08/2020 15:37
Aug 6 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* TIANJIN DEVELOPMENT- LISHENG PHARMACEUTICAL TO SUBSCRIBE
FOR
WEALTH MANAGEMENT PRODUCTS FOR RMB60 MILLION
* TIANJIN DEVELOPMENT - ON 7 JULY, LISHENG PHARMACEUTICAL
ENTERED
AGREEMENT WITH SPD BANK TO SUBSCRIBE FOR WEALTH MANAGEMENT
PRODUCTS WORTH RMB70 MILLION
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln